Bromfenac Sodium 0.09% w/v

Banzalkonium Chloride 0.01% w/v


Packing: 5ml



Nepafenac 0.1% w/v

Banzalkonium Chloride 0.01% w/v


Packing: 5ml

Further Detail <<

Topical corticosteroids and topical nonsteroidal antiinflammatory drugs (NSAIDs) are the two main options at surgeons’ disposal for controlling postoperative ocular inflammation. While both drug classes decrease inflammation, they have different properties and different mechanisms of action.Steroids block the inflammatory cascade at an early stage: the arachidonic acid pathway activated by tissue damage. But to be effective, steroids need to pass through cell membranes and enter the nucleus, which is limited because of their lipophobic nature. In addition, steroid side effects include intraocular pressure (IOP) elevation, delayed wound healing, and increased susceptibility to infection.NSAIDs block cyclooxygenase (COX-1 and COX-2), enzymes that convert arachidonic acid into the prostaglandins that directly mediate inflammation. NSAIDs enter cells readily and effectively shut down prostaglandin formation; within its class, the brominated NSAID bromfenac penetrates cells particularly well

Duravisc PF

Viscosight PF

Eye Drops


  • Bromsight

  • Inflow Tears


  • Mosight B

  • Clin

  • Inflow gel

  • Mosight

  • Flosight

  • Advance Tears

  • Mosight LP



  • nepasight

  • Nutrieye

  • Proeye